| PUBCHEM ID |
73416392
|
| UNII |
1I3N1X545L
|
| Preferred Term |
SENNOSIDE B CALCIUM
|
| CAS |
|
| INCHIKEY |
JQVYZJIFFAHQKX-YHPXQAAXSA-L
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
[O-]c(cc(cc1[C@H]([C@@H](c2c3c(O[C@H]([C@H]([C@@H]4O)O)O[C@@H](CO)[C@@H]4O)ccc2)c(cc(cc2[O-])C(O)=O)c2C3=O)c2cccc(O[C@H]([C@H]([C@@H]3O)O)O[C@@H](CO)[C@@H]3O)c22)C(O)=O)c1C2=O
|
| Total Surface Area |
565,62
|
| Relative PSA |
0,44503
|
| TPSA |
353,62
|
| cLogS |
-6,194
|
| MW |
860,728
|
| cLogP |
-4,1534
|
| H-Acceptors |
20
|
| H-Donors |
10
|
| Ro5 violations |
3
|
| Druglikeness |
-4,1623
|
| DrugScore |
0,158457543782224
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-1,0789
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Nucleus
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,0986
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,2916
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Ready biodegradable
|
| Acute Oral Toxicity |
IV
|
| Rat Acute Toxicity |
2,1859
|
| Carcinogenicity (Three-class) |
Non-required
|
